AzTrials
AzTrials

Spinal DeformityHEONCT01880164

Cost Effectiveness of Nonoperative Management for Adult Spinal Deformity

An observational study of Spinal Deformity, run by Shay Bess at 10 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Quantify the efficacy and cost of nonoperative treatment modalities used for adult spinal deformity. Read more about this study

Who is it for?
Ages 40 to 75 years
Conditions the study is for
Spinal Deformity
How many people
21 participants
Where
10 sitesUnited States
Study dates
Jun 2015to Apr 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult spinal deformity patients

Who may be able to join

  • Age 40-75 years of age at the time of enrollment.
  • ODI ≥30
  • Adult degenerative or idiopathic lumbar scoliosis 10-40° as measured by the Cobb angle technique
  • Sagittal plane deformity by SRS Schwab classification with at least one modifier ++ or two modifiers + and associated coronal cobb of at least 10 degrees

Who cannot join

  • Adult degenerative or idiopathic scoliosis with a curvature of the spine measuring <10 degrees or >40 degrees
  • Diagnosis of scoliosis other than degenerative or idiopathic (i.e. neuromuscular, congenital, etc.)
  • Cardiopulmonary disease or comorbidities that preclude surgical intervention
  • Patient not deemed surgical candidate by treating surgeon
  • Patient unwilling to commit to monthly phone interviews or completion of necessary questionnaires or inability to return for defined follow up time points. Patients unwilling to comply with study protocol will not be offered enrollment into the study, regardless of meeting inclusion criteria.

Trial locations and contacts

10 sites in 1 country.

10 sites in 1 country

United States10 sites
  • University of Virginia

    Charlottesville, Virginia, 22908

  • Rocky Mountain Scoliosis and Spine

    Denver, Colorado, 80205

  • University of Kansas Medical Center

    Kansas City, Kansas, 66160

  • Norton Leatherman Spine Center

    Louisville, Kentucky, 40202

  • NYU Hospital for Joint Diseases

    New York, New York, 10010

  • Hospital for Special Surgery

    New York, New York, 10021

  • Oregon Health Sciences University

    Portland, Oregon, 97239

  • University of California - Davis

    Sacramento, California, 95817

  • University of California - San Francisco Medical Center

    San Francisco, California, 94143

  • Washington University at St. Louis

    St Louis, Missouri, 63110

Other trials in United States

About this study

Official title: Cost Effectiveness of Nonoperative Management for Adult Spinal Deformity Associated With Low Grade Scoliosis: A Prospective Pilot Study to Evaluate Disease Burden and Longitudinal Study Feasibility

Quantify the efficacy and cost of nonoperative treatment modalities used for adult spinal deformity.

Read the detailed description
  1. Identify disease burden associated with adult spinal deformity (ASD) using quality adjusted life year (QALY) analysis.
  2. Identify disease burden of specific demographic and radiographic features associated with ASD.
  3. Compare disease burden of ASD to other musculoskeletal and non-musculoskeletal diseases.
  4. Identify efficacy of specific nonoperative treatment modalities to treat ASD and identify specific clinical and radiographic features of ASD responsive to nonoperative treatment modalities.
  5. Compare QALY and ICER values for different ASD nonoperative treatment modalities to previously established QALY and ICER for values for operative and nonoperative treatment modalities for degenerative hip and knee disease, coronary artery disease, insulin dependent diabetes, and hypertension.
  6. Evaluate the cost and work hours associated with data collection and minimum 85% patient follow up.
  7. Evaluate patient characteristics associated with poor patient compliance for study follow up including demographic, radiographic and HRQOL values and for reasons for cross-over to operative treatment for ASD.
  8. Establish standardized data collection methodology for economic based outcome studies based upon patient demographics and HRQOL values.
Keywords
Scoliosis, Kyphosis, Sagittal plane deformity
Medical subject headings
Scoliosis, Kyphosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01880164
Study groupRoleWhat they receive
NonoperativeAdult spinal deformity (degenerative or idiopathic) with an ODI of 30 or greater

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oswestry Disability Index (ODI)

    This questionnaire has been designed to provide information as to how back pain affects ability to manage in everyday life. Score must be equal to or greater than 30 for eligibility to enroll.

    Measured: Initial visit and six months post enrollment

Secondary outcomes (1)
  1. Radiographs

    Coronal and sagittal radiographic views of the spine obtained to assess coronal curvature and sagittal balance.

    Measured: Initial visit (Day 1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2013 (estimated)
  2. Study startJun 2015
  3. Primary completionJan 2017
  4. Study completionApr 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01880164
Sponsor's protocol ID
2108
Acronym
HEO
Status last verified
Apr 2017
First submitted
14 Jun 2013
Last updated
6 Apr 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Avorn J. Debate about funding comparative-effectiveness research. N Engl J Med. 2009 May 7;360(19):1927-9. doi: 10.1056/NEJMp0902427. No abstract available.

    PubMed 19420361
  • Baldus C, Bridwell KH, Harrast J, Edwards C 2nd, Glassman S, Horton W, Lenke LG, Lowe T, Mardjetko S, Ondra S, Schwab F, Shaffrey C. Age-gender matched comparison of SRS instrument scores between adult deformity and normal adults: are all SRS domains disease specific? Spine (Phila Pa 1976). 2008 Sep 15;33(20):2214-8. doi: 10.1097/BRS.0b013e31817c0466.

    PubMed 18794764
  • Berven S, Deviren V, Demir-Deviren S, Hu SS, Bradford DS. Studies in the modified Scoliosis Research Society Outcomes Instrument in adults: validation, reliability, and discriminatory capacity. Spine (Phila Pa 1976). 2003 Sep 15;28(18):2164-9; discussion 2169. doi: 10.1097/01.BRS.0000084666.53553.D6.

    PubMed 14501930
  • Bonham AC, Rich EC, Davis DA, Longnecker DE, Heinig SJ. Commentary: Putting evidence to work: an expanded research agenda for academic medicine in the era of health care reform. Acad Med. 2010 Oct;85(10):1551-3. doi: 10.1097/ACM.0b013e3181effdbc.

    PubMed 20703148
  • Bridwell KH, Berven S, Glassman S, Hamill C, Horton WC 3rd, Lenke LG, Schwab F, Baldus C, Shainline M. Is the SRS-22 instrument responsive to change in adult scoliosis patients having primary spinal deformity surgery? Spine (Phila Pa 1976). 2007 Sep 15;32(20):2220-5. doi: 10.1097/BRS.0b013e31814cf120.

    PubMed 17873814
  • Bridwell KH, Glassman S, Horton W, Shaffrey C, Schwab F, Zebala LP, Lenke LG, Hilton JF, Shainline M, Baldus C, Wootten D. Does treatment (nonoperative and operative) improve the two-year quality of life in patients with adult symptomatic lumbar scoliosis: a prospective multicenter evidence-based medicine study. Spine (Phila Pa 1976). 2009 Sep 15;34(20):2171-8. doi: 10.1097/BRS.0b013e3181a8fdc8.

    PubMed 19752703
  • Carter OD, Haynes SG. Prevalence rates for scoliosis in US adults: results from the first National Health and Nutrition Examination Survey. Int J Epidemiol. 1987 Dec;16(4):537-44. doi: 10.1093/ije/16.4.537.

    PubMed 3501989
  • Deyo RA, Mirza SK, Martin BI, Kreuter W, Goodman DC, Jarvik JG. Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. JAMA. 2010 Apr 7;303(13):1259-65. doi: 10.1001/jama.2010.338.

    PubMed 20371784
  • Everett CR, Patel RK. A systematic literature review of nonsurgical treatment in adult scoliosis. Spine (Phila Pa 1976). 2007 Sep 1;32(19 Suppl):S130-4. doi: 10.1097/BRS.0b013e318134ea88.

    PubMed 17728680
  • Garber AM, Tunis SR. Does comparative-effectiveness research threaten personalized medicine? N Engl J Med. 2009 May 7;360(19):1925-7. doi: 10.1056/NEJMp0901355. No abstract available.

    PubMed 19420360
  • Garrison KR, Donell S, Ryder J, Shemilt I, Mugford M, Harvey I, Song F. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technol Assess. 2007 Aug;11(30):1-150, iii-iv. doi: 10.3310/hta11300.

    PubMed 17669279
  • Glassman SD, Berven S, Kostuik J, Dimar JR, Horton WC, Bridwell K. Nonsurgical resource utilization in adult spinal deformity. Spine (Phila Pa 1976). 2006 Apr 15;31(8):941-7. doi: 10.1097/01.brs.0000209318.32148.8b.

    PubMed 16622386
  • Glassman SD, Bridwell K, Dimar JR, Horton W, Berven S, Schwab F. The impact of positive sagittal balance in adult spinal deformity. Spine (Phila Pa 1976). 2005 Sep 15;30(18):2024-9. doi: 10.1097/01.brs.0000179086.30449.96.

    PubMed 16166889
  • Glassman SD, Carreon LY, Shaffrey CI, Polly DW, Ondra SL, Berven SH, Bridwell KH. The costs and benefits of nonoperative management for adult scoliosis. Spine (Phila Pa 1976). 2010 Mar 1;35(5):578-82. doi: 10.1097/BRS.0b013e3181b0f2f8.

    PubMed 20118843
  • Glassman SD, Polly DW, Dimar JR, Carreon LY. The cost effectiveness of single-level instrumented posterolateral lumbar fusion at 5 years after surgery. Spine (Phila Pa 1976). 2012 Apr 20;37(9):769-74. doi: 10.1097/BRS.0b013e3181e03099.

    PubMed 20489676

Questions about this trial

What is this clinical trial studying?

An observational study of Spinal Deformity, run by Shay Bess at 10 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 10 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oswestry Disability Index (ODI) (time frame: Initial visit and six months post enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01880164, which also lists 35 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in